Interventions for muscular dystrophy: molecular medicines entering the clinic.

Lancet
Kate BushbyVolker Straub

Abstract

Muscular dystrophies are individually rare genetic disorders that cause much chronic disability, affecting young children and adults. In the past 20 years, more than 30 genetic types of muscular dystrophy have been defined. During this time, precise diagnosis, genetic counselling, and medical management have improved. These advances in medical practice have occurred while definitive therapies based on an improved knowledge of disease pathogenesis are awaited. A wide range of therapeutic options have been tested in animal models, and some are being tested in clinical trials. Various therapeutic targets are being investigated, from personalised medicines targeting specific mutations and drugs targeting cellular pathways to gene-based and cell-based therapies.

References

Sep 11, 2002·Neuromuscular Disorders : NMD·Marina BakayEric P Hoffman
Jan 1, 2003·Rheumatic Diseases Clinics of North America·Eric P HoffmanLauren M Pachman
Apr 2, 2003·Human Molecular Genetics·Annemieke Aartsma-RusJudith C T van Deutekom
Jul 23, 2003·Human Molecular Genetics·Bianca L GebskiStephen D Wilton
Oct 28, 2003·Human Gene Therapy·Gary P KobingerJames M Wilson
Jul 15, 2004·Journal of Cell Science·Michael J AllikianElizabeth M McNally
Dec 22, 2004·Human Gene Therapy·Norma B RomeroMichel Fardeau
Jul 21, 2005·European Journal of Human Genetics : EJHG·Tanja LalicJohan T den Dunnen
Aug 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Chunping QiaoXiao Xiao
Nov 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marc BartoliIsabelle Richard
Nov 25, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R TurkP A C 't Hoen
Dec 7, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Sherifa Ahmed Hamed, Eric P Hoffman
Jan 13, 2006·The New England Journal of Medicine·Christophe MeuneDenis Duboc
Jan 31, 2006·Trends in Molecular Medicine·Pedro Miura, Bernard J Jasmin
Apr 4, 2006·Journal of Human Genetics·Louis M KunkelLeta Steffen
Jun 30, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mary Lynn MercadoJustin R Fallon
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rahul N KanadiaMaurice S Swanson
Oct 14, 2006·The Journal of Clinical Investigation·Yutaka OhsawaYoshihide Sunada
Oct 27, 2006·Biochimica Et Biophysica Acta·Guy L OdomJeffrey S Chamberlain
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Francoise FougerousseIsabelle Richard
Jan 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Simon P QuennevilleJacques P Tremblay
Feb 8, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Steve D WiltonSusan Fletcher
Apr 24, 2007·Nature·Ellen M WelchH Lee Sweeney
Jul 7, 2007·BMC Medical Genetics·Annemieke Aartsma-RusJudith C T van Deutekom
Jul 27, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christina A PacakBarry J Byrne
Aug 28, 2007·American Heart Journal·Denis DubocHenri-Marc Bécane
Sep 12, 2007·Archives of Neurology·Louise R Rodino-KlapacJerry R Mendell
Sep 22, 2007·Current Opinion in Neurology·Francesco Muntoni, Dominic Wells
Oct 24, 2007·Molecular Biotechnology·Nikolaos VogiatzakisEmmanouel Kanavakis
Dec 28, 2007·The New England Journal of Medicine·Judith C van DeutekomGert-Jan B van Ommen
Jan 19, 2008·Journal of Molecular Neuroscience : MN·Mariz VainzofLydia U Yamamoto
Feb 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ming DuDavid M Bedwell

❮ Previous
Next ❯

Citations

Nov 2, 2012·Disease Models & Mechanisms·Joachim Berger, Peter D Currie
Sep 30, 2010·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Katherine E Wardrop, Janice A Dominov
Jun 28, 2014·Neuromuscular Disorders : NMD·H W van BruggenS I Kalaykova
Dec 15, 2015·Human Gene Therapy·Elisa NegroniVincent Mouly
Dec 19, 2015·Proteomics. Clinical Applications·Stijn OonkYuri E M van der Burgt
Aug 2, 2011·Experimental Physiology·Rebecca J FaircloughKay E Davies
Nov 19, 2014·Neuropathology and Applied Neurobiology·E NegroniC Trollet
Nov 10, 2011·Journal of Magnetic Resonance Imaging : JMRI·Bassem HibaMarc Janier
Dec 26, 2012·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Gaetano Thiene, Frank Marcus
Jan 12, 2011·Expert Opinion on Biological Therapy·Elisa NegroniCapucine Trollet
Nov 5, 2010·Arquivos de neuro-psiquiatria·Samara Lamounier Santana ParreiraUmbertina Conti Reed
Apr 26, 2011·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Kate Bushby
Nov 30, 2011·Nature Reviews. Cardiology·Cristina BassoGaetano Thiene
Jan 1, 2012·The American Journal of Case Reports·Stanley S LefkowitzJeremy Kethley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

The New England Journal of Medicine
Judith C van DeutekomGert-Jan B van Ommen
Expert Opinion on Biological Therapy
Elisa NegroniCapucine Trollet
Expert Opinion on Biological Therapy
Capucine TrolletGeorge Dickson
© 2022 Meta ULC. All rights reserved